Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA

Journal of Clinical Microbiology

Volumn 41, Issue 2, 2003, Pages 651-656

  Hendricks, David A ^a   Friesenhahn, Michel ^a   Tanimoto, Lorine ^a   Goergen, Bernd ^a,c   Dodge, Deborah ^a   Comanor, Lorraine ^a,b  

^a BAYER CORPORATION   (United States)

^b D G Bank ^*  (United States)

^c DG BANK Deutsche Genossenschaftsbank   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; EUROPE; EVALUATION; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C VIRUS; MULTICENTER STUDY; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RELIABILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRUS DETECTION;

GENOTYPE; HEPACIVIRUS; HUMANS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; VIRAL LOAD;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0037316589     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.2.651-656.2003     Document Type: Article

References (11)

1. Carithers, R. L., Jr., A. Marquardt, and D. R. Gretch. 2000. Diagnostic testing for hepatitis C. Semin. Liver Dis. 20:159-171.
2. Gorrin, G., M. Friesenhahn, P. Lin, M. Sanders, R. Pollner, B. Eguchi, J. Pham, G. Roma, J. Spidle, S. Nicol, C. Wong, S. Bhade, and L. Comanor. 2003. Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification. J. Clin. Microbiol. 41:310-317.
3. Irving, W. L. 2002. The role of the virology laboratory in the management of hepatitis C virus infection. J. Clin. Virol. 25:3-13.
4. Kleinbaum, D. G. 1992. Logistic regression: a self-learning text, p. 101-119. Springer-Verlag, New York, N.Y.
5. Krajden, M. 2000. Hepatitis C virus diagnosis and testing. Can. J. Public Health 91(Suppl. 1):S34-S39.
6. Krajden, M., R. Ziermann, A. Khan, A. Mak, K. Leung, D. Hendricks, and L. Comanor. 2002. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the COBAS AMPLICOR HCV test version 2.0 and the HCV RNA transcription-mediated amplification (TMA) qualitative assay. J. Clin. Microbiol. 40:2903-2907.
7. Pawlotsky, J. M. 2000. Hepatitis C viral markers and quasispecies, p. 25-52. In T. J. Liang and J. H. Hoofnagle (ed.), Hepatitis C: biomedical research reports. Academic Press, Inc., San Diego, Calif.
8. Pawlotsky, J. M. 2002. Molecular diagnosis of viral hepatitis. Gastroenterology 122:1554-1568.
9. Ross, R. S., S. O. Viazov, S. Hoffmann, and M. Roggendorf. 2001. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA. J. Clin. Lab. Anal. 15:308-313.
10. Saldanha, J. 2001. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J. Clin. Virol. 20:7-13.
11. Saldanha, J., N. Lelie, A. Heath, and the WHO Collaborative Study Group. 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 76:149-158.